Logo_NFL.png
  • About

    • Our Story
    • Leadership
    • Contact
  • Focus

    • Our Approach
    • Our Product
  • Pipeline

  • Investors

    • Press release
    • Regulated informations
    • Documents
    • Share information
    • General shareholders meeting
    • Calendar & Contact
  • PLUS

    Use tab to navigate through the menu items.
    EN
    EN
    FR
    Journaux

    Press 
    RELEASE

    Read and download the financial news from NFL Biosciences. To receive our announcements directly in your mailbox subscribe to our mailing list.

    May 11, 2022 • NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea

    April 11, 2022 • NFL BIOSCIENCES: Notice of allowance of its patent in China

    March 28, 2022 • NFL Biosciences: 2021 full-year business and earnings update

    February 2, 2022 • Co-development agreement for a drug candidate to reduce alcohol consumption

    December 14, 2021 • Phase II/III clinical trial launched for smoking cessation

    November 17, 2021 • Agreement signed with Diverchim to manufacture its active ingredients
    October 4, 2021 • 2021 half-year financial and business report
    September 21, 2021 • Approval for its patent to be granted in the United States

    September 15, 2021 • Phase II/III clinical trial for NFL-101 for smoking cessation approved in France

    September 6, 2021 • Analyst coverage launched with Invest Securities
    July 20, 2021 - Establishment of a liquidity agreement (in French only)

    June 30, 2021 • Success of the IPO on Euronext Growth Paris

    June 16, 2021 • NFL Biosciences launches its initial public offering on Euronext Growth Paris (in French only)

    June 2, 2021 • French smoking cessation innovation approved for Phase II clinical trial (in French only)

    NFL Biosciences

    ABOUT

    Our Story

    Leadership

    Contact

    ​

    FOCUS

    Our Approach

    Our Product

    ​

    ​

    PIPELINE

    ​

    INVESTORS

    Press release

    Regulated informations

    Financial documents

    Share information

    Calendar & Contact

    ADDRESS

    199 rue Hélène Boucher
    34170 Castelnau-Le-Lez
    France

    ​

    CONTACT

    +33.4.11.93.76.67 (Intl)

    04.11.93.76.67 (france)

     

    Personal Data            Legal Notice            ©2021 NFL Biosciences            Cookie Management            General terms of use